- Investigator
- Mehdi S Mirsaeidi
- Status
- Accepting Candidates
- Ages
- 18 Years - 100 Years
- Sexes
- All
Research at a glance
Top areas of exploration
- Mycobacterium tuberculosis , 21 publications
- Antitubercular Agents , 20 publications
- COVID-19 , 18 publications
- Tuberculosis, Pulmonary , 15 publications
Research activity
Active clinical trials
- Investigator
- Mehdi S Mirsaeidi
- Status
- Accepting Candidates
- Ages
- 18 Years - 100 Years
- Sexes
- All
- Investigator
- Mehdi S Mirsaeidi
- Status
- Accepting Candidates
- Ages
- 18 Years - 100 Years
- Sexes
- All
My publications
Filter publications
235 publications
2024
Risk of 30-Day All-Cause Readmission in Interstitial Lung Disease Patients after COVID-19: National-Level Data
Annals of the American Thoracic Society
Publisher's site2023
Acthar® Gel Treatment for Patients with Autoimmune and Inflammatory Diseases: An Historical Perspective and Characterization of Clinical Evidence.
Clinical drug investigation
PubMed • Publisher's site2023
Association of County-degree Social Vulnerability with Chronic Respiratory Disease Mortality in the United States
Annals of the American Thoracic Society
Publisher's site2023
Clinical standards for diagnosis, treatment and prevention of post-COVID-19 lung disease.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
PubMed • Publisher's site2023
Complete Genome Sequence of Pseudomonas aeruginosa Phage UF_RH6, Isolated from Human Lung
Microbiology Resource Announcements
PubMed • Publisher's site